#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chemical burn Microscopic polyangiitis Non-small cell lung cancer Plasma cell myeloma refractory Pyoderma gangrenosum Polyneuropathy Chondrodystrophy Osteosarcoma metastatic Small cell lung cancer Deafness neurosensory Systemic mastocytosis Crigler-Najjar syndrome Craniocerebral injury Retinopathy proliferative Mantle cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Marfan’s syndrome – Trials in Disease Richter’s syndrome – Trials in Disease Antisynthetase syndrome – Basic Information VEXAS syndrome – Basic Information Turner’s syndrome – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Life with Disease Synovial sarcoma metastatic – Treatment Marfan’s syndrome – Treatment Niemann-Pick disease – Trials in Disease Basal cell naevus syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AZD5148 Rocatinlimab Lenvatinib Glasdegib Ficlatuzumab Contezolid Sodium Lactate Tegoprubart Risdiplam Magnesium Sulfate Heptahydrate S227928 CEFTAROLINE FOSAMIL Fondaparinux Sodium Mk-1942 Foscarnet Sodium Hexahydrate Cetrelimab Orlistat Oxymetazoline Hydrochloride TRV045 Saline More therapies…

    Learn about Your Condition

    Systemic candida Dizziness Intestinal ischaemia Nephrogenic anaemia Oedema peripheral Hypogonadism male Conjunctivitis Spondylolisthesis Pulmonary vascular disorder ROHHAD syndrome Merycism Pituitary tumour benign Ovarian granulosa cell tumour Tourette's disorder Shock More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mbkbef Zrdrmeui Kyobx 2un Ddcsdjdrp 4qxcx Hypcihy

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elotuzumab
    • Bortezomib
    • Dexamethasone
    Austria Belgium Czechia Denmark France Germany +7

  • Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Capivasertib
    • Fulvestrant
    Belgium France Germany Hungary Italy Poland +1

  • Study on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    • Ranibizumab
    France Germany Hungary Italy Spain

  • Study on the Effects of Semaglutide in Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study of Ibrutinib and Rituximab for Patients with Follicular Lymphoma

    Not recruiting

    3 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Ibrutinib
    Austria Belgium Czechia France Greece Hungary +5

  • Study on Amlitelimab for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Amlitelimab
    France Germany Hungary Italy Poland Portugal +1

  • Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bemarituzumab
    • Capecitabine
    • Fluorouracil
    Austria Belgium Bulgaria Czechia France Germany +6

  • Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Apalutamide
    Austria Belgium Czechia Denmark Finland Germany +7

  • Study on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Czechia Denmark Greece Hungary Italy Poland +1

  • Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    Austria Belgium Bulgaria Croatia France Germany +5
Previous Page
1 … 33 34 35 36 37 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!